US Patent Issued to Sun Pharmaceutical Industries on June 2 for "Process for preparing enantiomerically enriched substituted pyrrolo[2,3-dpyrimidines" (Massachusetts, California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,902, issued on June 2, was assigned to Sun Pharmaceutical Industries Inc. (Princeton, N.J.).

"Process for preparing enantiomerically enriched substituted pyrrolo[2,3-dpyrimidines" was invented by Sean Wiedemann (Burlington, Mass.), Cameron J. Cowden (Lexington, Mass.), Patrick Bazinet (Somerville, Mass.), Kathryn E. Kavouris (Folsom, Calif.), Kuo-Ming Wu (Lexington, Mass.) and Robert S. Lewis (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Improved processes for preparing enantiomerically enriched intermediates for the synthesis of ruxolitinib and deuterated forms of ruxolitinib and deuterated analogs of ruxolitinib of Formula I: whe...